As a joint venture of the University of Basel and the University Hospitals Basel, the Department of Biomedicine (DBM) brings together basic and clinical scientists to advance our understanding of health and disease.
Department of Biomedicine🔬🧪
Loading...
Congratulations on this great achievement, Karen!👏
MISEV2023 sets key guidelines for EV research. With contributions from Edveena Hanser, Diego Kyburz, & an international consortium, the paper is now one of the top ten most-cited papers in JEV (Wiley, 2024).
Congratulations to everyone involved. isevjournals.onlinelibrary.wiley.com/doi/10.1002/...
🔬 Two new studies from the Pinschewer Lab at the DBM shed new light on antiviral immunity — from Lassa fever vaccination to B cell “attrition” in chronic infection. Congratulations to the team! 👏
Nature Communications: www.nature.com/articles/s41...
PNAS: www.pnas.org/doi/10.1073/...
Lifelong viral infections acquired at birth are not immunologically silent. A @biomedizin.unibas.ch & @unibas.ch study shows that Tfh-driven antibody responses partly control virus, but remain limited. Boosting CD4 T cell help may offer new therapeutic avenues.
www.sciencedirect.com/science/arti...
Welcome on board @magda-sznurkowska.bsky.social ! We are happy to have you with us, and we wish you a great start!
#Welcome2026 #TeamDBM #WelcomeOnBoard
@biomedizin.unibas.ch
DBM News: 🔗 biomedizin.unibas.ch/en/newsdetai...
The thirteenth issue of our DBM Newsletter is here! Happy reading!👇🏼👇🏼👇🏼
DBM Newsletter Issue 13: issuu.com/departementb...
@biomedizin.unibas.ch
#Newsletter #Research #Science #Biomedicine
Congratulations to Heinz Läubli on his appointment as Clinical Professor of Cellular Therapies at the @unibas.ch.
Heinz has helped establish Basel as a leader in translational cancer immunotherapy and innovative cell therapies, including as CAR-T and TIL cells.
biomedizin.unibas.ch/en/newsdetai...
New in Science Immunology: NK cells in lung cancer retain tumour-killing potential and can be reactivated via NKG2A checkpoint blockade. Great study from the Zippelius Lab at @biomedizin.unibas.ch. 🫁
👉 www.science.org/doi/10.1126/...
#LungCancer #Immunotherapy #NKCells
Department of Biomedicine🔬🧪
Department of Biomedicine🔬🧪
Department of Biomedicine🔬🧪
Pitch Lab @unibas.ch, Wed May 13, 5:30–8:30 PM at the Biozentrum.
Bring an early-stage idea or come as a collaborator. All faculties, all levels welcome. Food + drinks provided. One idea wins a prize + uniBIA support. Submit your idea: buff.ly/MQVphwt Come as collaborator: buff.ly/flpg40x
Department of Biomedicine🔬🧪
Department of Biomedicine🔬🧪
Department of Biomedicine🔬🧪
Department of Biomedicine🔬🧪
Department of Biomedicine🔬🧪
Graduate Center University of Basel
Perinatal infection often results in viral persistence, as observed for hepatitis B virus in humans. Commonly held concepts suggest that persistence i…
The University Council of the University of Basel has appointed Professor Heinz Läubli as Clinical Professor of Cellular Therapies at the Faculty of Medicine.
We are delighted to welcome Prof. Dr. Magdalena Sznurkowska as a new research group leader at the Department of Biomedicine, University of Basel. She will join our Department on May 1, 2026, where she...
Honoured to be part of this fantastic cohort pushing new directions in cancer research. Excited for what’s ahead!!
Karen Dixon
Congratulations to the recipients of the AACR Trailblazer Cancer Research Grants, supported by Pfizer. AACR’s largest-ever grant program has awarded 15 early-stage and mid-career investigators $1 million each to establish novel, highly creative research projects. www.aacr.org/about-the-aa...
